Evidence map›Paper›PMID 33445523›Full record

ArticleViruses2021

Identification of a New HIV-1 BC Intersubtype Circulating Recombinant Form (CRF108_BC) in Spain.

Javier E Cañada, Elena Delgado, Horacio Gil, Mónica Sánchez, Sonia Benito, Elena García-Bodas, Carmen Gómez-González, Andrés Canut-Blasco, Joseba Portu-Zapirain, Ester Sáez de Adana and 6 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Javier E CañadaHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.ORCID 0000-0002-8964-0551
Elena DelgadoHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Horacio GilHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.ORCID 0000-0002-7114-6686
Mónica SánchezHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Sonia BenitoHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Elena García-BodasHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Carmen Gómez-GonzálezDepartment of Microbiology, Hospital Universitario Araba, 01009 Vitoria-Gasteiz, Spain.
Andrés Canut-BlascoDepartment of Microbiology, Hospital Universitario Araba, 01009 Vitoria-Gasteiz, Spain.
Joseba Portu-ZapirainBioaraba, Infectious Diseases Research Group, 01009 Vitoria-Gasteiz, Spain.
Ester Sáez de AdanaDepartment of Infectious Diseases-Internal Medicine, Hospital Universitario Araba, 01009 Vitoria-Gasteiz, Spain.
Mireia De la PeñaDepartment of Infectious Diseases, Hospital Universitario Basurto, 48013 Bilbao, Spain.
Sofía IbarraDepartment of Infectious Diseases, Hospital Universitario Basurto, 48013 Bilbao, Spain.ORCID 0000-0002-1456-737X
Gustavo CillaBiodonostia, Department of Microbiology, Hospital Universitario Donostia, 20080 San Sebastián, Spain.
José Antonio IribarrenBiodonostia, Department of Infectious Diseases, Hospital Universitario Donostia, 20080 San Sebastián, Spain.ORCID 0000-0003-4013-8509
Ana Martínez-SapiñaDepartment of Microbiology, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.
Michael M ThomsonHIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Instituto de Salud Carlos III · ESHospital Universitario Araba · ESBiogipuzkoa Health Research Institute · ESHospital de Basurto · ESHospital Universitario Miguel Servet · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extraordinary genetic variability of human immunodeficiency virus type 1 (HIV-1) group M has led to the identification of 10 subtypes, 102 circulating recombinant forms (CRFs) and numerous unique recombinant forms. Among CRFs, 11 derived from subtypes B and C have been identified in China, Brazil, and Italy. Here we identify a new HIV-1 CRF_BC in Northern Spain. Originally, a phylogenetic cluster of 15 viruses of subtype C in protease-reverse transcriptase was identified in an HIV-1 molecular surveillance study in Spain, most of them from individuals from the Basque Country and heterosexually transmitted. Analyses of near full-length genome sequences from six viruses from three cities revealed that they were BC recombinant with coincident mosaic structures different from known CRFs. This allowed the definition of a new HIV-1 CRF designated CRF108_BC, whose genome is predominantly of subtype C, with four short subtype B fragments. Phylogenetic analyses with database sequences supported a Brazilian ancestry of the parental subtype C strain. Coalescent Bayesian analyses estimated the most recent common ancestor of CRF108_BC in the city of Vitoria, Basque Country, around 2000. CRF108_BC is the first CRF_BC identified in Spain and the second in Europe, after CRF60_BC, both phylogenetically related to Brazilian subtype C strains.

Indexed as

Genome, ViralGenotypeRecombination, GeneticGenetic VariationHIV-1HIV InfectionsHumansMolecular EpidemiologyPhylogenyPhylogeographyPublic Health SurveillanceSequence Analysis, DNASpainViremiacirculating recombinant formHIV-1HIV-1 genetic diversityHIV-1 molecular epidemiologyHIV-1 phylogeny

Identifiers

PMID33445523
PMCPMC7826730
OpenAlexW3118344421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.